Evolent Health, Inc. (NYSE: EVH)
Health Care · Health Care Technology · US
$4.89
+3.60% today · -49.6% 1Y
Evolent Health, Inc. (NYSE: EVH) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $552.86M and employs 4,200 people.
Over the last twelve months the share price has lost 49.6%, trading between 2.10 and 10.08.
Tweenvest scores Evolent Health, Inc. across four factors: quality 47/100, value 69/100, growth 100/100. Its strongest factor is growth.
EVH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $552.86M
- Revenue (TTM)
- $2.10B
- P/E
- —
- EPS
- -4.54
- Dividend yield
- —
- Beta (5Y)
- 0.78
- 52-week high
- $10.08
- 52-week low
- $2.10
- Avg volume (3M)
- —
- Shares outstanding
- 113.06M
- Employees
- 4,200
- Next earnings
- —
About Evolent Health, Inc.
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
- ISIN
- US30050B1017
- Founded
- 2011
- Listed since
- Jun 5, 2015
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Veeva Systems Inc.NYSE: VEEV | $40.09B | $243.62 | -1.28% |
| Pro Medicus LimitedASX: PME | $14.25B | AU$190.60 | -1.46% |
| M3, Inc.TSE: 2413 | $7.33B | ¥1,750.00 | +1.77% |
| Sectra AB (publ)OM: SECT B | $5.62B | Skr276.20 | +0.15% |
| Waystar Holding Corp.NasdaqGS: WAY | $4.64B | $24.16 | -0.21% |
| Doximity, Inc.NYSE: DOCS | $4.41B | $24.63 | -0.46% |
| HeartFlow, Inc.NasdaqGS: HTFL | $4.34B | $49.89 | -0.62% |
| Inventurus Knowledge Solutions LimitedNSEI: IKS | $3.30B | Rs1,840.00 | +6.43% |
Figures last refreshed Aug 18, 2026.